semaglutide flow Assessing the Safety of and Tirzepatide in Black and Asian Populations: A Narrative Review FLOWing with the SemagluTIDE —

Synjardy is an oral diabetes medicine that combines empagliflozin with metformin in one tablet

In a study of more than 400 patients, roughly one in five experienced heightened taste sensitivity, and many reported being less hungry and more easily satisfied.

Sustainable long-term weight loss

Food companies are investing more in freezer meals specifically marketed to GLP-1 users

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)

This activation enhances insulin secretion, regulates glucose levels, and helps control appetite